Bullseye Biodevices develops biosensing technology for real-time tissue assessment, tumor detection, and surgical care.
Bullseye Biodevices has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in August 2026.
Bullseye Biodevices is headquartered in Hoboken, United States.
Bullseye Biodevices develops biosensing technology for real-time tissue assessment, tumor detection, and surgical care.
Bullseye Biodevices is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bullseye Biodevices — Funding & Investors." VCBacked, August 6, 2026, https://www.vcbacked.co/company/bullseye-biodevices. Accessed October 31, 2026.
VCBacked. (2026). Bullseye Biodevices — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/bullseye-biodevices
{{cite web |title=Bullseye Biodevices — Funding & Investors |url=https://www.vcbacked.co/company/bullseye-biodevices |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated